Competence of Thiamin Diphosphate-Dependent Enzymes with 2′-Methoxythiamin Diphosphate Derived from Bacimethrin, a Naturally Occurring Thiamin Anti-vitamin
Abstract:Bacimethrin (4-amino-5-hydroxymethyl-2-methoxypyrimidine), a natural product isolated from some bacteria, has been implicated as an inhibitor of bacterial and yeast growth, as well as in inhibition of thiamin biosynthesis. Given that thiamin biosynthetic enzymes could convert bacimethrin to 2′-methoxythiamin diphosphate (MeOThDP), it is important to evaluate the effect of this coenzyme analogue on thiamin diphosphate (ThDP)-dependent enzymes. The potential functions of MeOThDP were explored on five ThDP-depend… Show more
“…Anerobic conditions were established either in a Baker-Ruskinn in vivo (Sanford, ME) or a Coy Laboratory Products vinyl anaerobic chamber (Grass Lake, MI). E. coli WT DXP synthase and E. coli MEP synthase (IspC) were overexpressed and purified as reported previously with minor modifications for the purification of anaerobic DXP synthase (14,34). To obtain anaerobic DXP synthase, the protein was overexpressed and purified as previously described (34), however, the second dialysis was carried out in an anaerobic chamber in 50 mM HEPES, pH 8, 5% glycerol, 100 mM NaCl, 10 mM MgCl 2 , and 1 mM ThDP at 0°C for 4 h. The protein was stored in liquid N 2 until use when it was transferred directly to an anaerobic chamber.…”
The underexploited antibacterial target 1-deoxy-d-xyluose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate (d-GAP). DXP is an essential intermediate in the biosynthesis of ThDP, pyridoxal phosphate, and isoprenoids in many pathogenic bacteria. DXP synthase catalyzes a distinct mechanism in ThDP decarboxylative enzymology in which the first enzyme-bound pre-decarboxylation intermediate, C2α-lactyl-ThDP (LThDP), is stabilized by DXP synthase in the absence of d-GAP, and d-GAP then induces efficient LThDP decarboxylation. Despite the observed LThDP accumulation and lack of evidence for C2α-carbanion formation in the absence of d-GAP, CO is released at appreciable levels under these conditions. Here, seeking to resolve these conflicting observations, we show that DXP synthase catalyzes the oxidative decarboxylation of pyruvate under conditions in which LThDP accumulates. O-dependent LThDP decarboxylation led to one-electron transfer from the C2α-carbanion/enamine to O, with intermediate ThDP-enamine radical formation, followed by peracetic acid formation to acetate. Thus, LThDP formation and decarboxylation and DXP formation were studied under anaerobic conditions. Our results support a model in which O-dependent LThDP decarboxylation and peracetic acid formation occur in the absence of d-GAP, decreasing the levels of pyruvate and O in solution. The relative pyruvate and O concentrations then dictate the extent of LThDP accumulation, and its buildup can be observed when [pyruvate] > [O]. The finding that O acts as a structurally distinct trigger of LThDP decarboxylation supports the hypothesis that a mechanism involving small molecule-dependent LThDP decarboxylation equips DXP synthase for diverse, yet uncharacterized cellular functions.
“…Anerobic conditions were established either in a Baker-Ruskinn in vivo (Sanford, ME) or a Coy Laboratory Products vinyl anaerobic chamber (Grass Lake, MI). E. coli WT DXP synthase and E. coli MEP synthase (IspC) were overexpressed and purified as reported previously with minor modifications for the purification of anaerobic DXP synthase (14,34). To obtain anaerobic DXP synthase, the protein was overexpressed and purified as previously described (34), however, the second dialysis was carried out in an anaerobic chamber in 50 mM HEPES, pH 8, 5% glycerol, 100 mM NaCl, 10 mM MgCl 2 , and 1 mM ThDP at 0°C for 4 h. The protein was stored in liquid N 2 until use when it was transferred directly to an anaerobic chamber.…”
The underexploited antibacterial target 1-deoxy-d-xyluose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate (d-GAP). DXP is an essential intermediate in the biosynthesis of ThDP, pyridoxal phosphate, and isoprenoids in many pathogenic bacteria. DXP synthase catalyzes a distinct mechanism in ThDP decarboxylative enzymology in which the first enzyme-bound pre-decarboxylation intermediate, C2α-lactyl-ThDP (LThDP), is stabilized by DXP synthase in the absence of d-GAP, and d-GAP then induces efficient LThDP decarboxylation. Despite the observed LThDP accumulation and lack of evidence for C2α-carbanion formation in the absence of d-GAP, CO is released at appreciable levels under these conditions. Here, seeking to resolve these conflicting observations, we show that DXP synthase catalyzes the oxidative decarboxylation of pyruvate under conditions in which LThDP accumulates. O-dependent LThDP decarboxylation led to one-electron transfer from the C2α-carbanion/enamine to O, with intermediate ThDP-enamine radical formation, followed by peracetic acid formation to acetate. Thus, LThDP formation and decarboxylation and DXP formation were studied under anaerobic conditions. Our results support a model in which O-dependent LThDP decarboxylation and peracetic acid formation occur in the absence of d-GAP, decreasing the levels of pyruvate and O in solution. The relative pyruvate and O concentrations then dictate the extent of LThDP accumulation, and its buildup can be observed when [pyruvate] > [O]. The finding that O acts as a structurally distinct trigger of LThDP decarboxylation supports the hypothesis that a mechanism involving small molecule-dependent LThDP decarboxylation equips DXP synthase for diverse, yet uncharacterized cellular functions.
“…The overall activity of PDHc containing either WT or ␣V138M E1 was measured by monitoring the formation of NADH (and H ϩ ) at 340 nm, as reported previously (22). PDHc was reconstituted by premixing the E1, E2⅐E3BP, and E3 proteins at a microgram mass ratio of 1:3:3 in a buffer of 50 mM KH 2 PO 4 (pH 7.0) and 0.15 M NaCl for 60 min at 25°C (31).…”
The pyruvate dehydrogenase multienzyme complex (PDHc) connects glycolysis to the tricarboxylic acid cycle by producing acetyl-CoA via the decarboxylation of pyruvate. Because of its pivotal role in glucose metabolism, this complex is closely regulated in mammals by reversible phosphorylation, the modulation of which is of interest in treating cancer, diabetes, and obesity. Mutations such as that leading to the αV138M variant in pyruvate dehydrogenase, the pyruvate-decarboxylating PDHc E1 component, can result in PDHc deficiency, an inborn error of metabolism that results in an array of symptoms such as lactic acidosis, progressive cognitive and neuromuscular deficits, and even death in infancy or childhood. Here we present an analysis of two X-ray crystal structures at 2.7-Å resolution, the first of the disease-associated human αV138M E1 variant and the second of human wildtype (WT) E1 with a bound adduct of its coenzyme thiamin diphosphate and the substrate analogue acetylphosphinate. The structures provide support for the role of regulatory loop disorder in E1 inactivation, and the αV138M variant structure also reveals that altered coenzyme binding can result in such disorder even in the absence of phosphorylation. Specifically, both E1 phosphorylation at αSer-264 and the αV138M substitution result in disordered loops that are not optimally oriented or available to efficiently bind the lipoyl domain of PDHc E2. Combined with an analysis of αV138M activity, these results underscore the general connection between regulatory loop disorder and loss of E1 catalytic efficiency.
“…1). The design principles and general modus operandi of these antivitamins are highly similar as they all bear a small chemical modification of the vitamin scaffold, are taken up by the target species in the form of a modified precursor and are eventually transformed by the native downstream machinery responsible for biosynthesis of the biologically active cofactor form, often with higher affinity than the native cofactor, to yield the mature cofactor analog [6][7][8][9][10][11] .…”
mentioning
confidence: 99%
“…A set of enzyme targets for MThDP was identified in E. coli, namely α-ketoglutarate dehydrogenase, transketolase (TK) and 1-deoxy-d-xylulose-5 -phosphate synthase (DXS). In vitro studies on several ThDP enzymes demonstrated that the enzymatic activities of both E. coli pyruvate dehydrogenase (EcPDH) and E. coli 1-deoxy-d-xylulose-5 -phosphate synthase are strongly inhibited upon reconstitution with MThDP 11 . Conversely, E. coli α-ketoglutarate dehydrogenase and human PDH retain almost full enzymatic activity with MThDP as the cofactor 11 .…”
mentioning
confidence: 99%
“…In vitro studies on several ThDP enzymes demonstrated that the enzymatic activities of both E. coli pyruvate dehydrogenase (EcPDH) and E. coli 1-deoxy-d-xylulose-5 -phosphate synthase are strongly inhibited upon reconstitution with MThDP 11 . Conversely, E. coli α-ketoglutarate dehydrogenase and human PDH retain almost full enzymatic activity with MThDP as the cofactor 11 . This underscores the notion that MThDP is, in principle, coenzymatically active, but it remains unclear why only some ThDP enzymes are inhibited by MThDP.…”
The natural antivitamin 2′-methoxy-thiamine (MTh) is implicated in the suppression of microbial growth. However, its mode of action and enzyme-selective inhibition mechanism have remained elusive. Intriguingly, MTh inhibits some thiamine diphosphate (ThDP) enzymes, while being coenzymatically active in others. Here we report the strong inhibition of Escherichia coli transketolase activity by MTh and unravel its mode of action and the structural basis thereof. The unique 2′-methoxy group of MTh diphosphate (MThDP) clashes with a canonical glutamate required for cofactor activation in ThDP-dependent enzymes. This glutamate is forced into a stable, anticatalytic low-barrier hydrogen bond with a neighboring glutamate, disrupting cofactor activation. Molecular dynamics simulations of transketolases and other ThDP enzymes identify active-site flexibility and the topology of the cofactor-binding locale as key determinants for enzyme-selective inhibition. Human enzymes either retain enzymatic activity with MThDP or preferentially bind authentic ThDP over MThDP, while core bacterial metabolic enzymes are inhibited, demonstrating therapeutic potential.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.